Copyright Reports & Markets. All rights reserved.

Global Neuroendocrine Tumor Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Neuroendocrine Tumor Drug Market Overview

      • 1.1 Product Overview and Scope of Neuroendocrine Tumor Drug
      • 1.2 Neuroendocrine Tumor Drug Segment by Type
        • 1.2.1 Global Neuroendocrine Tumor Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 mTOR protein inhibitors
        • 1.2.3 Tyrosine kinase 3 inhibitors
        • 1.2.4 Somatostatin receptor antagonists
        • 1.2.5 Growth hormone releasing factor antagonists
        • 1.2.6 Somatostatin receptor agonists
        • 1.2.7 Others
      • 1.3 Neuroendocrine Tumor Drug Segment by Application
        • 1.3.1 Neuroendocrine Tumor Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Neuroendocrine Tumor Drug Market by Region
        • 1.3.1 Global Neuroendocrine Tumor Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Neuroendocrine Tumor Drug Market Size
        • 1.4.1 Global Neuroendocrine Tumor Drug Revenue (2014-2025)
        • 1.4.2 Global Neuroendocrine Tumor Drug Production (2014-2025)

      2 Global Neuroendocrine Tumor Drug Market Competition by Manufacturers

      • 2.1 Global Neuroendocrine Tumor Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Neuroendocrine Tumor Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Neuroendocrine Tumor Drug Production Sites, Area Served, Product Types
      • 2.5 Neuroendocrine Tumor Drug Market Competitive Situation and Trends
        • 2.5.1 Neuroendocrine Tumor Drug Market Concentration Rate
        • 2.5.2 Neuroendocrine Tumor Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Neuroendocrine Tumor Drug Production Market Share by Regions

      • 3.1 Global Neuroendocrine Tumor Drug Production Market Share by Regions
      • 3.2 Global Neuroendocrine Tumor Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Neuroendocrine Tumor Drug Production
        • 3.4.1 North America Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Neuroendocrine Tumor Drug Production
        • 3.5.1 Europe Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Neuroendocrine Tumor Drug Production (2014-2019)
        • 3.6.1 China Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Neuroendocrine Tumor Drug Production (2014-2019)
        • 3.7.1 Japan Neuroendocrine Tumor Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Neuroendocrine Tumor Drug Consumption by Regions

      • 4.1 Global Neuroendocrine Tumor Drug Consumption by Regions
      • 4.2 North America Neuroendocrine Tumor Drug Consumption (2014-2019)
      • 4.3 Europe Neuroendocrine Tumor Drug Consumption (2014-2019)
      • 4.4 China Neuroendocrine Tumor Drug Consumption (2014-2019)
      • 4.5 Japan Neuroendocrine Tumor Drug Consumption (2014-2019)

      5 Global Neuroendocrine Tumor Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Neuroendocrine Tumor Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Neuroendocrine Tumor Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Neuroendocrine Tumor Drug Price by Type (2014-2019)
      • 5.4 Global Neuroendocrine Tumor Drug Production Growth by Type (2014-2019)

      6 Global Neuroendocrine Tumor Drug Market Analysis by Applications

      • 6.1 Global Neuroendocrine Tumor Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Neuroendocrine Tumor Drug Business

      • 7.1 Eisai
        • 7.1.1 Eisai Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.1.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.1.3 Eisai Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Exelixis, Inc.
        • 7.2.1 Exelixis, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.2.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Foresee Pharmaceuticals, LLC
        • 7.3.1 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.3.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Hutchison MediPharma Limited
        • 7.4.1 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.4.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Intezyne, Inc
        • 7.5.1 Intezyne, Inc Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.5.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 INVENT Pharmaceuticals, Inc.
        • 7.6.1 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.6.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Ipsen S.A.
        • 7.7.1 Ipsen S.A. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.7.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Jiangsu Hengrui Medicine Co., Ltd.
        • 7.8.1 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.8.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Karyopharm Therapeutics, Inc.
        • 7.9.1 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.9.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Lexicon Pharmaceuticals, Inc.
        • 7.10.1 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
        • 7.10.2 Neuroendocrine Tumor Drug Product Introduction, Application and Specification
        • 7.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Midatech Pharma Plc .
      • 7.12 Millennium Pharmaceuticals, Inc.
      • 7.13 MolMed S.p.A.
      • 7.14 Northwest Biotherapeutics, Inc.
      • 7.15 Novartis AG
      • 7.16 OctreoPharm Sciences GmbH
      • 7.17 OXiGENE, Inc.

      8 Neuroendocrine Tumor Drug Manufacturing Cost Analysis

      • 8.1 Neuroendocrine Tumor Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug
      • 8.4 Neuroendocrine Tumor Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Neuroendocrine Tumor Drug Distributors List
      • 9.3 Neuroendocrine Tumor Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Neuroendocrine Tumor Drug Market Forecast

      • 11.1 Global Neuroendocrine Tumor Drug Production, Revenue Forecast
        • 11.1.1 Global Neuroendocrine Tumor Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Neuroendocrine Tumor Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Neuroendocrine Tumor Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Neuroendocrine Tumor Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Neuroendocrine Tumor Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Neuroendocrine Tumor Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Neuroendocrine Tumor Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Neuroendocrine Tumor Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Neuroendocrine Tumor Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Neuroendocrine Tumor Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Neuroendocrine Tumor Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Neuroendocrine Tumor Drug Consumption Forecast (2019-2025)
      • 11.4 Global Neuroendocrine Tumor Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Neuroendocrine Tumor Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Neuroendocrine Tumor Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Neuroendocrine Tumor Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroendocrine Tumor Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Eisai
        Exelixis, Inc.
        Foresee Pharmaceuticals, LLC
        Hutchison MediPharma Limited
        Intezyne, Inc
        INVENT Pharmaceuticals, Inc.
        Ipsen S.A.
        Jiangsu Hengrui Medicine Co., Ltd.
        Karyopharm Therapeutics, Inc.
        Lexicon Pharmaceuticals, Inc.
        Midatech Pharma Plc .
        Millennium Pharmaceuticals, Inc.
        MolMed S.p.A.
        Northwest Biotherapeutics, Inc.
        Novartis AG
        OctreoPharm Sciences GmbH
        OXiGENE, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        mTOR protein inhibitors
        Tyrosine kinase 3 inhibitors
        Somatostatin receptor antagonists
        Growth hormone releasing factor antagonists
        Somatostatin receptor agonists
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now